tiprankstipranks
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market
SYRE
Spyre Therapeutics
RESEARCH TOOLSreports
Want to see SYRE full AI Analyst Report?

Spyre Therapeutics (SYRE) Balance Sheet

553 Followers

Spyre Therapeutics Balance Sheet

Spyre Therapeutics's total assets for Q1 2026 were $763.95M, a decrease of -1.78% from the previous quarter. SYRE total liabilities were $93.14M for the fiscal quarter, a 48.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 777.78M$ 608.48M$ 341.86M$ 71.14M$ 109.93M
Total Liabilities
$ 62.55M$ 90.68M$ 157.84M$ 20.84M$ 25.98M
Total Equity Gross Minority
$ 715.24M$ 517.80M$ 184.02M$ 50.30M$ 83.94M
Other Metrics
Currency in USD

Spyre Therapeutics Debt to Assets